On the ninth day of Christmas life science gave to me…

We’ve created our very own 12 days of Christmas for the life science sector. Medical Plastics News, Digital Health Age and European Pharmaceutical Manufacturer put a festive feel on the news in 2016.

On the ninth day of Christmas life science gave to me…

Startups expanding

Alongside the big names in the digital health industry this year were a number of startups who showed promise, obtaining funding for technology and services they’d developed to help people with a range of conditions and needs.

Across the water, Swedish startup Natural Cycles developed an app designed to help women conceive. Natural Cycle’s app works by identifying a woman’s ovulation and fertile window by tracking her period and temperature. Women can take their temperature from underneath their tongue, then record the data into the app which then utilises the unique algorithm, determining whether women are fertile on any specific day.

It’s definitely successful and has over 100,000 users in 161 countries. The company has raised $6 million funding to conduct new clinical studies and aid international expansion and has also donated $25 million worth of free subscriptions to women in Brazil to help fight the Zika virus.

Closer to home an Edinburgh-based tech company received £2 million in funding for the development for its wearable health monitoring device.

Founded by a former Dundee University medical student Christopher McCann, snap40, developed a wearable armband that continuously monitors patient’s vital signs, notifying doctors if the patient shows signs of deterioration.

The company received what is thought to be the largest investment of its kind awarded to a Scotland-based startup. The funding was led by investment firm Par Equity and will allow the company to expand into the EU market. They will do this through growing its engineering and data science team, completing clinical trials and gaining regulatory clearance.

In Paris Dataiku and Bioserenity developed a wearable device to help doctors diagnose epilepsy. The wearable device, created by Bioserenity, is combined with a data analysis platform built by Dataiku. It aims to offer neurologists a tool for accurately diagnosing epilepsy through a mobile and continuous electroencephalogram (EEG) recording.

It monitors patients in real-time and aims to help doctors effectively diagnose epilepsy. Diagnosing and monitoring epilepsy can be difficult as seizures can often occur in the absence of medical staff.

London based startup Patients Pending announced its new product, a Bluetooth enabled dose capture cap that the company hopes will provide data and more automated care for diabetic patients.

The device, like the original Timesulin smart replacement cap, is compatible with leading insulin pens. The device aims to aid patients and caregivers with data that is not currently available such as personalised dosing support, coaching and patient/clinical communication.

CEO and co-founder John Sjölund, who has been living with Type 1 diabetes for over 30 years said: “When insulin and continuous blood glucose data are combined on a smartphone, the resulting possibilities of providing individually personalised dosing and behaviour recommendations – at the right time – is game-changing.”

Also this year, recognising the potential of startups Creative innovation firm Comuzi and leading international law firm, Simmons & Simmons partnered up to provide free open hour advisory sessions for digital health startups.

The event saw digital health-startups provided with the opportunity to gain knowledge and specific advice, particularly around innovation and the legal challenges of being in the digital health sector.

Reece Armstrong is a reporter for Digital Health Age. Coming from the North East of England, Reece has an MA in Media & Journalism and a BA in Popular & Contemporary Music from Newcastle University. Reach him on Twitter or email via: reece.armstrong@rapidnews.com

'On the ninth day of Christmas life science gave to me…' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions